Printer Friendly

Articles from M2 Pharma (July 20, 2016)

1-14 out of 14 article(s)
Title Author Type Words
ASPiRA LABS signs strategic coverage agreement for OVA1 in Michigan via Priority Health Managed Benefits. 243
Auris Medical signs up to USD20m loan facility agreement with Hercules Capital. 196
Bristol-Myers Squibb unveils US FDA approved ORENCIA (abatacept) ClickJect for adults with moderate to severe rheumatoid arthritis. 239
Eiger BioPharmaceuticals doses first patient in Phase 2 LIBERTY study of Ubenimex. Clinical report 208
Essential Medica'sl Manta Large Bore Vascular Closure Device Approved for CE Mark. 211
Lannett reports US FDA Acceptable Filing letter for Fentanyl Patch ANDA. 227
MabVax Therapeutics Starts Patient Enrollment in Phase I Trial of Diagnostic Imaging Product for Pancreatic Cancer. 484
Medical Compression Systems names new chief executive officer. 115
Migraine Medical Device Cefaly Releases Revamped Model of Headband. 330
Samsung Bioepis submits SB5 marketing authorisation application to European Medicines Agency. 162
Thesan Pharmaceuticals names new chairman. 166
Tiziana Life Sciences acquires Sardinian region genetic data from Shardna. 159
US FDA Clears Syneron Candela's High Energy UltraShape Power for Fat Destruction. 277
Valeant and Progenics wins US FDA approval for RELISTOR Tablets for treating OIC in adults with chronic non-cancer pain. 244

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters